CoffeeAndMilk

Govt draws hard line on injectable beauty products

India's drug regulator has told clinics and consumers that cosmetics cannot be injected into the body. The clarification brings glutathione drips and anti-ageing shots under sharper scrutiny.

by · India Today

In Short

  • Regulator said cosmetic products are meant only for external application
  • Clinics have marketed glutathione drips and brightening therapies with bold claims
  • Doctors warned patients often remain unaware of what gets injected

India’s booming beauty clinic industry is facing an unprecedented regulatory glare as authorities move to crack down on the rampant use of injectable “cosmetic” products being marketed as anti-ageing and skin-enhancing treatments.

From Botox parties in upscale salons to glutathione “skin whitening” drips offered in neighbourhood aesthetic clinics, a fast-expanding market has thrived in a legal grey zone. Now, the Central Drugs Standard Control Organisation (CDSCO) has drawn a hard line: cosmetics cannot be injected into the human body.

In a sharply worded communication, the national drug regulator clarified that cosmetics, as defined under the Drugs and Cosmetics Act, 1940, are products meant to be “rubbed, poured, sprinkled or sprayed” on the body for cleansing or beautifying purposes. Injectable preparations, the CDSCO stressed, do not fall within that definition.

The clarification comes amid growing concern over beauty clinics and wellness centres offering glutathione injections, anti-ageing cocktails and skin “brightening” therapies with aggressive marketing claims and little regulatory oversight.

The regulator noted that no cosmetic is permitted to be used through injection by consumers, professionals or aesthetic clinics. Cosmetics, it reiterated, are intended only for external application and not for treatment purposes.

The order also warns against misleading claims and the use of prohibited ingredients in cosmetic products. Under existing rules, no cosmetic can claim effects that are false or deceptive, and tampering with product labels or manufacturer markings is prohibited.

Industry insiders say the move could disrupt a lucrative urban beauty business that has exploded over the last decade, fuelled by social media trends, celebrity endorsements and growing demand for “preventive anti-ageing” treatments among younger consumers.

Glutathione injections, in particular, have gained popularity as a purported skin-lightening and detoxifying therapy despite repeated questions from medical experts over their long-term safety and efficacy.

Similarly, injectable anti-ageing treatments are increasingly being administered outside hospital settings, often in clinics with limited emergency care facilities.

The CDSCO warning effectively puts such practices under scrutiny if products classified as cosmetics are being injected or promoted with therapeutic claims.

'TREATMENT OFTEN IRRATIONAL'

Veteran dermatologist Dr Kabir Sardana said the regulator’s clarification addresses a serious public health concern that has been building for years.

“Consumers are often made to believe these injections are harmless beauty enhancers, while many products are being used in ways never approved under the law,” he said. “There is a dangerous overlap today between cosmetics, drugs and aesthetic procedures, and patients frequently do not know what exactly is being injected into them.”

Doctors also warn that unregulated injectable procedures carry risks ranging from allergic reactions and infections to liver and kidney complications in extreme cases. The absence of standard treatment protocols and uneven practitioner qualifications have added to concerns.

The regulator has also underlined that cosmetics are not permitted for “treatment” by professionals or individuals, reinforcing the distinction between approved drugs and cosmetic products. Legal experts say this could expose clinics making medical or therapeutic claims to regulatory action under the Drugs and Cosmetics Act and Cosmetics Rules, 2020.

The crackdown comes at a time when India’s aesthetic medicine market is witnessing rapid growth, with services once limited to elite dermatology centres now widely available in malls, salons and online-led wellness chains.

- Ends